DIAMOND BAR, Calif. and MINNEAPOLIS, May 7 /PRNewswire/ -- Biosense Webster, Inc., the world leader in cardiac mapping and ablation, and Medtronic, Inc. (NYSE: MDT - News), the world leader in implanted cardiac rhythm devices, today announced plans to collaborate on a clinical trial, educational initiatives and a product development program, all of which are aimed at advancing the care of patients with cardiac arrhythmias, also known as irregular heartbeats.
